Mostrando 10 resultados de: 37
Subtipo de publicación
Article(37)
Área temáticas
Farmacología y terapéutica(31)
Enfermedades(23)
Fisiología humana(10)
Cirugía y especialidades médicas afines(7)
Fisiología y materias afines(7)
Área de conocimiento
Farmacología(24)
Descubrimiento de fármacos(8)
Inflamación(8)
Medicina interna(8)
Inmunología(6)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(35)
ODS 17: Alianzas para lograr los objetivos(16)
ODS 6: Agua limpia y saneamiento(14)
ODS 10: Reducción de las desigualdades(11)
ODS 12: Producción y consumo responsables(11)
Origen
scopus(37)
A preterm rat model for immunonutritional studies
ArticleAbstract: Neonates are born with an immature immune system, which develops during the first stages of life. ThPalabras claves:Adaptive immunity, innate immunity, Intestinal permeability, Phagocytosis, Plasmatic immunoglobulin, Prematurity, Suckling ratAutores:Abril-Gil M., Castell M., Franch A., Grases-Pintó B., Paulina Torres-Castro, Pérez-Cano F.J., Rodríguez-Lagunas M.J.Fuentes:scopusThermoreversible gel-loaded amphotericin B for the treatment of dermal and vaginal candidiasis
ArticleAbstract: The present study was designed to develop a thermoreversible gel of Pluronic (P407) loaded amphoteriPalabras claves:Amphotericin B, Candidiasis, Poloxamer 407, Skin and vaginal mucosa, Thermoreversible gelAutores:Bozal N., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rincón M., Rodríguez-Lagunas M.J., Silva-Abreu M., Sosa L.Fuentes:scopusThiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease
ArticleAbstract: Pioglitazone (PGZ) is a member of the thiazolidinedione (TZDs) family of drugs and it is primarily uPalabras claves:Alzheimer's disease, Geriatric patients, Mucosal permeation, Oral administration, Pioglitazone, ThiazolidinedionesAutores:Calpena A.C., Espina M., García M.L., Gonzalez-Pizarro R., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusTopical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model
ArticleAbstract: Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show aPalabras claves:Atopic dermatitis, Nanoemulsion, Pioglitazone, Pluronic F127Autores:Badia J., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M., Vera-García R.Fuentes:scopusTGF-β2, EGF, and FGF21 growth factors present in breast milk promote mesenteric lymph node lymphocytes maturation in suckling rats
ArticleAbstract: Breast milk, due to its large number of nutrients and bioactive factors, contributes to optimal devePalabras claves:Breast milk, cytokines, Growth factors, Immunonutrition, LymphocytesAutores:Abril-Gil M., Castell M., Franch A., Paulina Torres-Castro, Pérez-Cano F.J., Rodríguez-Lagunas M.J.Fuentes:scopusEfficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation
ArticleAbstract: Apremilast (APM) is a novel drug for the treatment of psoriasis and psoriatic arthritis. APM is a phPalabras claves:Apremilast, CARBOMER 940, Imiquimod, Pluronic F127, Sepigel 305®, skin formulations, topical psoriasisAutores:Calpena A.C., Fábrega M.J., Garduño-Ramírez M.L., Lupe Carolina Espinoza, Mallandrich M., Rincón M., Rodríguez-Lagunas M.J., Silva-Abreu M., Sosa L.Fuentes:scopusCharacterization and In Vivo Anti-Inflammatory Efficacy of Copal (Dacryodes peruviana (Loes.) H.J. Lam) Essential Oil
ArticleAbstract: Essential oils are natural aromatic substances that contain complex mixtures of many volatile compouPalabras claves:Dacryodes peruviana, Essential oil, inflammation, limonene, Α-phellandreneAutores:Calpena A.C., Eduardo Valarezo, Fábrega M.J., Lupe Carolina Espinoza, Mallandrich M., Rodríguez-Lagunas M.J., Sosa L.Fuentes:scopusApremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation
ArticleAbstract: Apremilast (APR) is a selective phosphodiesterase 4 inhibitor administered orally in the treatment oPalabras claves:Apremilast, inflammation, Microemulsion, Phosphodiesterase 4, Skin DiseasesAutores:Badia J., Calpena A.C., Díaz-Garrido N., Fábrega M.J., Halbaut L., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusEffect of Penetration Enhancers and Safety on the Transdermal Delivery of Apremilast in Skin
ArticleAbstract: The poor water solubility of apremilast (APR) is the main impediment to the penetration of the drugPalabras claves:Apremilast, Promoter, Skin, squaleneAutores:Alvarado H., Baldomá L., Calpena A.C., Díaz-Garrido N., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J.Fuentes:scopusEnhanced transdermal delivery of pranoprofen using a thermo-reversible hydrogel loaded with lipid nanocarriers for the treatment of local inflammation
ArticleAbstract: A biocompatible topical thermo-reversible hydrogel containing Pranoprofen (PF)-loaded nanostructuredPalabras claves:inflammation, nanostructured lipid carriers, Pranoprofen, Thermo-reversible hydrogel, Transdermal deliveryAutores:Calpena A.C., Colom H., Lupe Carolina Espinoza, Rincón M., Rodríguez-Lagunas M.J., Silva-Abreu M., Sosa L.Fuentes:scopus